Skip to content

AUPH

Aurinia Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$16.90
−0.35%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 3, 2026
EPS estimate
$0.21
Revenue estimate
$83.6M

Latest reported

Last report date
Aug 6, 2026
EPS actual
$0.28
EPS estimate
$0.24
Revenue actual
$83.2M
Revenue estimate
$80.4M

Track record

Trailing twelve quarters

EPS beats (12Q)
11
EPS misses (12Q)
1
EPS in line (12Q)
0
Avg surprise (4Q)
+62.4%
Revenue beats (12Q)
10

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$16
PT range
$16 – $16
Analysts
2
1 Buy1 Hold0 Sell
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 6, 2026$0.24$0.28Beat 16.67%$83.2M
May 7, 2026$0.18$0.25Beat 38.89%$77.7M
Jul 31, 2025$0.17$0.16Miss -5.88%$70.0M
Feb 27, 2025$0.03$0.09Beat 200.00%$59.9M
Nov 7, 2024$0.01$0.10Beat 566.67%$67.8M
Aug 1, 2024$0.02$0.02Beat 20.05%$57.2M
May 2, 2024-$0.17-$0.03Beat 82.35%$50.3M
Nov 2, 2023-$0.17-$0.09Beat 47.06%$54.5M
Aug 3, 2023-$0.18-$0.08Beat 55.56%$41.5M
May 4, 2023-$0.22-$0.18Beat 18.18%$34.4M
Feb 28, 2023-$0.27-$0.18Beat 33.33%$28.4M
Nov 3, 2022-$0.17-$0.06Beat 64.71%$55.8M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026